|
1. |
Intravenous immunoglobulin in the treatment of human immunodeficiency virus‐related thrombocytopenia |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 261-266
Mark U. Rarick,
Terri Montgomery,
Amitabha Mazumder,
Parkash S. Gill,
Carmen Loureiro,
Alexandra M. Levine,
Susan Groshen,
Jane Sullivan‐Halley,
Denise Jamin,
Preview
|
PDF (532KB)
|
|
摘要:
AbstractFourteen patients with sexually transmitted human immunodeficiency virus (HIV)‐related immune thrombocytopenia were treated with intravenous gammaglobulin (IVIG). The patients were treated with a uniform program consisting of 1 g/kg of IVIG on day 1 and day 2, followed by 1 g/kg on day 15. Most patients had pretreatment bleeding symptoms, which included petechiae, spontaneous and traumatic ecchymoses, gum bleeding, and epistaxis. Median baseline platelet count was 17,000/mm3(range 3–61,000/mm3). After the infusion of the IGIV, all patients had a resolution of their bleeding by day 8. The median maximum platelet count achieved with the IGIV was 220,000/mm3(range 76–426,000/mm3). No patient achieved either a sustained complete or partial remission after the conclusion of the IVIG therapy. Toxicities were minimal with the majority being headache and nausea. In conclusion, patients with sexually transmitted HIV infection and immune thrombocytopenia respond favorably to IVIG. This treatment should be considered as first‐line therapy for patients with HIV‐related immune thrombocytopenia who require immediate but temporary increase in their platelet count, attributable to symptoms or signs of clinical bleeding or because of the need for an invasive
ISSN:0361-8609
DOI:10.1002/ajh.2830380402
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
2. |
Epirubicin and cytosine arabinoside for the induction therapy of childhood acute nonlymphocytic leukemia |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 267-270
Der‐Cherng Liang,
Chang‐Jen Jiang,
Preview
|
PDF (323KB)
|
|
摘要:
AbstractEpirubicin, a new anthracycline, was used in combination with cytosine arabinoside for the induction therapy of de novo acute nonlymphocytic leukemia in childhood. The treatment consisted of epirubicin 20 mg/m2/day for 3 days and cytosine arabinoside 100 mg/m2/day for 7 days. The treatment could be repeated every 3 weeks. Remission induction rate was 80% (20/25). Moreover, in 13 patients, the remissions were obtained after a single course. In general, the side effects of epirubicin and cytosine arabinoside were tolerable. However, the main causes of all the three deaths were infections. Our study suggests that epirubicin is acceptable and effective for the induction therapy for de novo acute nonlymphocytic leukemia in childhood.
ISSN:0361-8609
DOI:10.1002/ajh.2830380403
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
3. |
Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 271-276
M. Ciaudo,
M. H. Horellou,
C. De Carbonnieres,
J. Conard,
M. Samama,
J. Audouin,
Preview
|
PDF (593KB)
|
|
摘要:
AbstractPrimary lymphoma of the spleen is characterized by predominant splenomegaly. Lymphoplasmacytic malignant lymphoma of the spleen, of low malignancy in the Kiel classification, low and intermediate grade in the National Cancer Institute Working Formulation (NCIWF), is rare. It is often associated with a monoclonal immunoglobulin M (IgM).Four patients presenting with primary splenic lymphoma of plasmacytic type associated with a high level of monoclonal IgM and a lupus anticoagulant (LA) are described. This association has not previously been reported. In contrast with the usual heterogeneity of LA, this LA is relatively homogeneous with an important prolongation of the prothrombin time (>18 see for a control of 12), more prolonged partial thromboplastin time (PTT) of the mixture patient + control plasma than PTT of the patient plasma. Despite the important coagulation abnormalities, none of these four patients has presented any hemorrhagic or thrombotic complications, even during major surgery such as splenectomy.The lupus‐like anticoagulant effect ran parallel with the monoclonal IgM. Survival, after splenectomy and chemotherapy, appears to be favourable: three patients are alive with survivals of ≧7 years. The follow‐up is as yet too short for the last pa
ISSN:0361-8609
DOI:10.1002/ajh.2830380404
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
4. |
Hemoglobin constant spring in bangkok: Molecular screening by selective enzymatic amplification of the α2‐globin gene |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 277-280
V. Thonglairoam,
S. Fucharoen,
V. S. Tanphaichitr,
P. Pung‐amritt,
S. H. Embury,
P. Winichagoon,
P. Wasi,
Preview
|
PDF (401KB)
|
|
摘要:
AbstractHemoglobin Constant Spring (Hb CS) is a hemoglobin variant with an elongated α‐globin chain secondary to a chain termination mutation. The diagnosis of HbCS by electrophoresis is difficult because it is present in very low amounts in the red cells of heterozygotes. Selective enzymatic amplification of the α2‐globin gene and allele‐specific hybridization for Hb CS gene provided accurate diagnosis of Hb Constant Spring. We have used this approach to detect the αcsmutation in the cord blood that contained all four α‐globin genes but had Hb Bart on electrophoresis. The αcsmutation was found in six subjects whose Hb Bart levels were 3.0, 3.2, 3.7, 4.0, 4.9, and 9.8%. The latter also had −α mutation on the other chromosome, giving rise to the genotype αcsα/−α, which produced high Hb Bart. The gene frequency for αcsin the Thai calculated from a total of 406 cord blood studied in Bangkok w
ISSN:0361-8609
DOI:10.1002/ajh.2830380405
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
5. |
Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 281-287
Hidesaku Asakura,
Hiroshi Jokaji,
Masanori Saito,
Chika Uotani,
Ichiro Kumabashiri,
Eriko Morishita,
Masahide Yamazaki,
Tamotsu Matsuda,
Preview
|
PDF (501KB)
|
|
摘要:
AbstractWe examined the changes in plasma levels of soluble thrombomodulin in 66 cases of disseminated intravascular coagulation (DIC), to investigate the damage to vascular endothelial cells and its relationship to multiple organ failure. A significant elevation of plasma levels of soluble thrombomodulin was observed in most cases of DIC, especially in patients with sepsis. However, no such significant elevation was observed in patients with acute promyelocytic leukemia. Plasma levels of both soluble thrombomodulin and active plasminogen activator inhibitor were higher in the cases of DIC with multiple organ failure than in those without multiple organ failure. The levels of soluble thrombomodulin were decreased with the clinical improvement in most cases of DIC but were further increased or remained at high levels in patients who showed no improvement of DIC. It was suggested that an increase in soluble thrombomodulin indicates the damage to the vascular endothelial cells in cases of DIC and that the damage to vascular endothelial cells plays some role in further progression of multiple organ failure.
ISSN:0361-8609
DOI:10.1002/ajh.2830380406
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
6. |
An effective acute graft‐vs.‐host disease prophylaxis with minidose methotrexate, cyclosporine, and single‐dose methylprednisolone |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 288-292
Jonathan C. Yau,
Susan D. Huan,
Meletios A. Dimopoulos,
Shiao Y. Woo,
Lane J. Brunner,
Ralph O. Wallerstein,
Albert B. Deisseroth,
Borje S. Andersson,
Verneeda Spencer,
Gary Spitzer,
C. Frederick LeMaistre,
Preview
|
PDF (480KB)
|
|
摘要:
AbstractCyclosporine and methotrexate at standard doses (15 mg/m2on day 1 and 10 mg/m2on days 3, 6, and 11, total 45 mg/m2) are effective in the prophylaxis of actue graft‐vs.‐host disease. However, the combination has significant early toxicities with delayed engraftment, increased mucositis, and hepatotoxicity. We modified the combination by adding single‐dose methylprednisolone and lowered the total dose of methotrexate to 35 mg/m2(5 mg/m2on days 1, 3, and 6, and then 10 mg/m2on days 11 and 18) and then to 20 mg/m2(5 mg/m2on days 1, 3, 6, and 11) in an attempt to decrease these side effects in two sequential consecutive groups of patients. We demonstrated that the modified regimens maintained the efficacy with reduced toxicities. The rate of engraftment was comparable to cyclosporine alone and the hepatotoxicity was reduced with reduced doses of methotrexate. Factors such as early immunosuppression of the host, intravenous immunoglobulin, the timing of steroid administration, nucleotide free diet and germ free environment may contribute to the effectiveness of the combination and permit reduction of methotrexate
ISSN:0361-8609
DOI:10.1002/ajh.2830380407
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
7. |
Characterization of novel platelet and endothelial cell target antigens in a family with genetic susceptibility to autoimmunity |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 293-303
Sofia Hashemi,
Elise Trudel,
Peter R. Ganz,
Jeanne Drouin,
Roger Couture,
Denis Page,
M. T. Aye,
Preview
|
PDF (1131KB)
|
|
摘要:
AbstractThis report describes a French Canadian family whose members exhibit a high incidence of allo‐ and autoantibodies to antigens present on both platelets and endothelial cells. This is correlated with various HLA specificities known to be associated with autoimmunity, such as A1, B8, DR3, and, in some cases, with clinical disorders, including nephritis, hypertension, and thrombocytopenia. Immunoblot analysis using platelet and endothelial cell lysates showed serum antibodies to a 75 kDa endothelial cell surface polypeptide and to polypeptides with apparent mass of 115 kDa and 26 kDa found on both platelets and endothelial cells. This 115 kDa internal platelet protein was also found in a variety of other cell types, such as mononuclear cells, and increased following cell activation. Monoclonal antibody immunobilization assays were used to characterize the 26 kDa polypeptide; in three of the four patients tested, an antibody to leukocyte differentiation antigen CD9 was identified. The asymptomatic child of the propositus also exhibited an autoantibody against an 80 kDa platelet protein which was sensitive to thrombin digestion, suggesting that this polypeptide may be platelet glycoprotein V. In addition, PIA1alloantibody was identified in one sister who had given birth to a severely thrombocytopenic boy and who herself had a severe vascular rejection to a cadaver kidney 2 years prior to this study. The propositus also developed hypertensive renal disease following a pregnancy and became dialysis dependent. Thus, members of this family have developed a variety of antibodies, particularly to platelet and endothelial cell antigens. Some subjects have remained asymptomatic in spite of having autoantibodies. However, others have been seriously ill, and their immune response to these antigens is believed to have played a role in the pathogenesis of their neonatal alloimmune thrombocytopenic purpura, hypertensive renal disease, renal graft rejection, and thrombocytopeni
ISSN:0361-8609
DOI:10.1002/ajh.2830380408
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
8. |
The single ζ globin gene rearrangement: Hematologic phenotype and its frequent occurrence in polynesian niueans |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 304-306
R. J. Trent,
J. Yakas,
J. Rutherford,
K. N. P. Mickleson,
Preview
|
PDF (299KB)
|
|
摘要:
AbstractThe single ζ globin gene rearrangement (−ζ/) is an unusual mutation associated with the α globin gene cluster on chromosome 16p13.3. It has been detected regularly among West Africans (gene frequency ˜0.05) and sporadically among other populations. DMA samples from 186 Polynesian Niueans living in Auckland, New Zealand, were studied. Eighteen (gene frequency 0.05) were shown to have the −ζ/ gene rearrangement, which results from loss of the Ψζ1 gene. Hematological phenotypes in six cord blood samples and 12 affected adults were normal. The high frequency for −ζ/ in Niueans may represent another example of genetic drift and a founder effect in Polynesians or may reflect a different foundi
ISSN:0361-8609
DOI:10.1002/ajh.2830380409
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
9. |
Platelet thrombospondin and glycoprotein IV abnormalities in patients with essential thrombocythemia: Effect of α‐interferon treatment |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 307-313
C. Legrand,
S. Bellucci,
M. Disdier,
G. Tobelem,
L. Edelman,
Preview
|
PDF (621KB)
|
|
摘要:
AbstractPlatelet aggregability and some biochemical parameters were evaluated in seven patients with essential thrombocythemia (ET) compared with seven patients with secondary thrombocytosis (ST). Defective platelet aggregation with one or more agonists was seen in five patients with ET whereas aggregation was increased in two other patients. In addition, three patients with ET demonstrated spontaneous platelet aggregation in citrated plasma. This was associated with increased level of thrombospondin (TSP) in the plasma membrane. Interestingly, the presence of a proteolyzed 160 kDa form of TSP was detected in all patients with ET, whereas it was never found in patients with ST. Furthermore, three patients with ET demonstrated increased levels of platelet surface glycoprotein IV (GP IV), the putative receptor for TSP in the plasma membrane. In two of these patients, this correlated with increased surface expression of TSP and spontaneous platelet aggregation. The results suggest a possible link between the increased number of plasma membrane GP IV molecules, the spontaneous expression of TSP on the platelet surface and platelet hyperaggregability in some ET patients. The levels of plasma membrane GP IV and platelet surface‐associated TSP tended to be normalized during α‐interferon treatment, whereas the presence of an altered form of TSP persisted. This last parameter might be of practical usefulness in the characterization of the disease, permitting a clear distinction fro
ISSN:0361-8609
DOI:10.1002/ajh.2830380410
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
10. |
Simple method for differentiating between HLA and platelet‐specific antibodies by flow cytometry |
|
American Journal of Hematology,
Volume 38,
Issue 4,
1991,
Page 314-320
J. Freedman,
A. Hornstein,
Preview
|
PDF (616KB)
|
|
摘要:
AbstractSince platelets express both platelet‐specific and class I HLA antigens, serum antiplatelet reactivity assessed by most platelet antibody techniques could be due to antibodies with either or both specificities. Flow cytometric analysis of sera for detection of anti platelet antibody commonly employs a purified platelet preparation as target cells. A method is described for investigating sera for platelet antibodies by flow cytometry using a mixture of platelets and lymphocytes. The mixture of lymphocytes and platelets as target cells has the advantage of confirming the presence of the HLA antibodies in reactive sera. The concomitant use of platelets and lymphocytes treated with citric acid, pH3, or with chloroquine (to remove or alter surface HLA antigens without affecting platelet specific antigens) may further assist in identifying antiplatelet antibodies in alloimmunized patients. These techniques may also be useful in platelet crossmatching procedure
ISSN:0361-8609
DOI:10.1002/ajh.2830380411
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1991
数据来源: WILEY
|
|